)
Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Key Features API-first headless architecture with complete frontend freedom (React, Next.js, Vue, any framework) Native subscription engine with flexible billing, automated retry, dunning, mixed carts, pause/resume Multi-gateway payment support: Stripe, Braintree, Authorize.net, PayPal, Saferpay, QuickPay, plus custom processor integrations Unlimited product variants and custom attributes with no cap on options or SKU combinations Custom data models for prescription fields, compliance metadata, and insurance information Visual store builder plus full headless option for omnichannel selling 230 currencies, 170 languages natively included Full-stack app platform with serverless functions, CLI tooling, and clean API documentation PCI DSS Level 1, GDPR, CCPA compliant Revenue-based fee structure above plan thresholds, competitive with other platforms' percentage-based transaction fees Best for: Semaglutide brands that need native subscriptions, multi-gateway payment flexibility, unlimited product variants, and an API-first architecture that scales from launch through enterprise growth without replatforming
It belongs to a novel class of agents known as triple agonists , meaning it simultaneously activates three distinct hormone receptors: GIP receptor (glucose-dependent insulinotropic polypeptide) GLP-1 receptor (glucagon-like peptide-1) Glucagon receptor This triple mechanism of action distinguishes retatrutide from currently approved agents such as semaglutide (a GLP-1 receptor agonist) or tirzepatide (a dual GIP/GLP-1 agonist)
The earlier Phase 2 work in adults with type 2 diabetes (published in 2023) similarly demonstrated meaningful reductions in HbA1c and body weight
We also offer complementary wellness services like medical weight loss and aesthetic treatments that many patients combine with peptide therapy for comprehensive care
First-month weight loss of 24 pounds is a healthy, sustainable rate that reflects appetite suppression and calorie reduction without extreme restriction
